睡眠对药物耐药性的直肠和直肠网络动态的不同影响
Sana Hannan1,2, John Thomas1, Kassem Jaber1
1Analytical Neurophysiology Lab, Montreal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada.
Annals of neurology
|September 15, 2023
概括
非快速眼球运动 (NREM) 睡眠会增加焦点间接性发性排放 (IED),但不会改变患者的发作传播. 这表明,一旦突破了发作值,动态是独立于睡眠阶段的.
科学领域:
- 神经科学是一个神经科学.
- 发病学 (Epileptology) 是一个专业的学科.
- 睡眠医学 睡眠医学
背景情况:
- 睡眠显著影响大脑活动,包括焦点间接性形放电 (IED),已知在非快速眼动 (NREM) 睡眠期间增加.
- 然而,睡眠对发作本身的动态的影响,特别是它们的空间和时间特征,仍然不太了解.
研究的目的:
- 研究NREM睡眠对焦点发作发作的时空空间动态的影响.
- 为了比较这些 ictal 动态与不同警觉状态期间的 interictal 网络动态.
主要方法:
- 分析了25名耐药焦点患者的内电脑图 (iEEG) 数据.
- 在清醒和NREM睡眠期间记录了发作和间接性发性排泄 (IED).
- 在睡眠和清醒状态之间比较了时空传播,发作,持续时间和IED率.
主要成果:
- 发作发作,持续时间和传播模式在清醒和NREM睡眠之间没有显著差异.
- 与清醒相比,在NREM睡眠期间,IED的发射率和空间分布显著更高.
- 在警状态中,扣押的空间重叠比IED更大.
结论:
- NREM睡眠不会改变焦点中发作的时空动态,与它对IED的影响不同.
- 这表明,一旦达到发作值,活动遵循已建立的网络,无论警状态如何.
- 这些发现为中神经网络行为提供了关键的见解,并可能有助于发作焦点定位.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
210
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
210
Overview of Synapses
2.4K
A synapse is a specialized structure where two neurons connect, allowing them to pass an electrical or chemical signal to another neuron. It is the point of communication between neurons. The term "synapse" is derived from the Greek word "synapsis," which means "conjunction." The entire process of neural communication revolves around the synapse. When activated, a neuron releases chemicals known as neurotransmitters into the synapse. These neurotransmitters cross the synapse and bind to...
2.4K
Substance Use Disorders Affecting Sleep
196
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
196
Arteries of the Lower Limbs
212
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
212
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
339
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
339


